Sizing up stability: combination therapy with Apo-AI peptide mimetics and statins in systemic lupus erythematosus-mediated atherosclerosis

scientific article published on September 15, 2010

Sizing up stability: combination therapy with Apo-AI peptide mimetics and statins in systemic lupus erythematosus-mediated atherosclerosis is …
instance of (P31):
editorialQ871232
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1025031004
P356DOI10.1186/AR3115
P953full work available at URLhttp://www.biomedcentral.com/content/pdf/1478-6354-12-139.pdf
http://www.biomedcentral.com/1478-6354/12/139
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20854650/?tool=EBI
https://europepmc.org/articles/PMC2990990
https://europepmc.org/articles/PMC2990990?pdf=render
http://www.biomedcentral.com/1478-6354/12/139/abstract
https://arthritis-research.biomedcentral.com/counter/pdf/10.1186/ar3115
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20854650/pdf/?tool=EBI
P932PMC publication ID2990990
P698PubMed publication ID20854650
P5875ResearchGate publication ID46380168

P2093author name stringYanice Mendez-Fernandez
Amy Major
P2860cites workEffects of a 3-month course of rosuvastatin in patients with systemic lupus erythematosusQ43277482
The bimodal mortality pattern of systemic lupus erythematosusQ43703475
Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterolQ43862770
Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide.Q53667385
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham StudyQ73106702
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosusQ33974679
Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosisQ34027495
Statin treatment for rheumatoid arthritis: a promising novel indicationQ37027316
Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosisQ37731826
Total synthesis of chondramide C and its binding mode to F-actinQ39961903
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectatherosclerosisQ12252367
P304page(s)139
P577publication date2010-09-15
P1433published inArthritis Research and TherapyQ15757229
P1476titleSizing up stability: combination therapy with Apo-AI peptide mimetics and statins in systemic lupus erythematosus-mediated atherosclerosis
P478volume12

Reverse relations

cites work (P2860)
Q34938841Aortic Atherosclerosis in Systemic Lupus Erythematosus
Q92783907Human Lupus Plasma Pro-Atherogenic Effects on Cultured Macrophages Are Not Mitigated by Statin Therapy: A Mechanistic LAPS Substudy

Search more.